TXRH(TXRH)
TXRH
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $6.54B | $7.15B | $7.76B | $8.28B | $9.11B |
| Low | $6.51B | $7.06B | $7.55B | $8.14B | $8.96B |
| High | $6.56B | $7.24B | $7.93B | $8.39B | $9.23B |
| EBITDA Avg | $777M | $850M | $923M | $984M | $1.08B |
| Low | $774M | $839M | $898M | $968M | $1.06B |
| High | $779M | $860M | $942M | $998M | $1.10B |
| EBIT Avg | $560M | $613M | $665M | $710M | $781M |
| Low | $558M | $605M | $647M | $698M | $768M |
| High | $562M | $620M | $679M | $719M | $791M |
| Net Income Avg | $425M | $500M | $588M | $640M | $714M |
| Low | $417M | $456M | $578M | $626M | $699M |
| High | $438M | $524M | $679M | $651M | $727M |
| EPS Avg | $6.44 | $7.67 | $9.27 | $9.62 | $10.74 |
| Low | $6.27 | $6.86 | $8.68 | $9.41 | $10.51 |
| High | $6.58 | $7.88 | $10.21 | $9.79 | $10.93 |
| Analysts (Rev / EPS) | 20 / 20 | 19 / 19 | 10 / 7 | 9 / 2 | 9 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.59B | $1.64B | $1.78B | $1.83B | $1.73B | $1.79B | $1.93B | $1.99B |
| Low | $1.58B | $1.62B | $1.77B | $1.81B | $1.72B | $1.77B | $1.91B | $1.97B |
| High | $1.60B | $1.65B | $1.80B | $1.84B | $1.75B | $1.80B | $1.95B | $2.00B |
| EBITDA Avg | $189M | $195M | $212M | $217M | $206M | $213M | $230M | $236M |
| Low | $188M | $193M | $210M | $215M | $204M | $210M | $227M | $234M |
| High | $190M | $196M | $214M | $219M | $208M | $214M | $232M | $238M |
| EBIT Avg | $136M | $140M | $153M | $157M | $149M | $153M | $166M | $170M |
| Low | $135M | $139M | $151M | $155M | $147M | $152M | $164M | $168M |
| High | $137M | $142M | $154M | $158M | $150M | $155M | $167M | $172M |
| Net Income Avg | $87M | $93M | $143M | $143M | $107M | $116M | $171M | $175M |
| Low | $82M | $92M | $141M | $141M | $105M | $114M | $169M | $173M |
| High | $91M | $94M | $144M | $144M | $108M | $117M | $173M | $177M |
| EPS Avg | $1.32 | $1.42 | $2.16 | $2.17 | $1.62 | $1.75 | $2.60 | $2.65 |
| Low | $1.24 | $1.40 | $2.13 | $2.14 | $1.60 | $1.73 | $2.57 | $2.62 |
| High | $1.37 | $1.43 | $2.19 | $2.19 | $1.64 | $1.77 | $2.63 | $2.68 |
| Analysts (Rev / EPS) | 15 / 17 | 9 / 7 | 7 / 7 | 7 / 15 | 7 / 9 | 7 / 7 | 13 / 9 | 13 / 8 |